DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma REMoDL-B Phase 3 Study: Evaluation of Molecular Guided Therapy for DLBCL Apr 20, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Residual Disease Kinetics in High-Risk CLL Patients: Ibr+Ven vs Clb+O Mar 23, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Real-World Comparison of ACP-196 and Ibrutinib in CLL Treatment Mar 23, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Safety and Tolerability of Pirtobrutinib in B-Cell Malignancies: BRUIN Phase 1/2 Study Mar 07, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma A Promising Phase 1/2 Study of Pirtobrutinib in R/R CLL/SLL Patients Pre-Treated with cBTKi Mar 07, 2023
Lymphoma,MZL (Marginal Zone Lymphoma) Long-term Outcomes of Axi-cel CAR T-cell Therapy in iNHL Patients - ZUMA-5 Study Mar 01, 2023
Lymphoma,MZL (Marginal Zone Lymphoma) Research on Pirtobrutinib Safe and Effective for RT Patients with DLBCL Mar 01, 2023
FL (Follicular Lymphoma),Lymphoma,Popular Comparing HRQOL in R/R Large B-cell Lymphoma: Liso-cel vs SOC Feb 24, 2023
